{
  "main_header": {
    "sid": 1002804,
    "name": "Vaishali Pharma",
    "stock_name": "Vaishali Pharma",
    "full_name": "Vaishali Pharma Ltd",
    "name_url": "stocks-analysis/vaishali-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.42",
    "chg": -0.22,
    "chgp": "-2.55%",
    "dir": -1,
    "prev_price": "8.64",
    "mcapval": "94.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "VAISHALI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE972X01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 94228,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vaishali-pharma-1002804-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3749661",
        "imagepath": "",
        "date": "2025-12-06 01:40:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Vaishali Pharma’s share price decline on 05-Dec reflects broader challenges the company faces. The stock is trading close to its 52-week low, just 2.02% above ₹8.25, signalling sustained pressure on investor confidence. On the day, the stock underperformed its sector by 2.34%, and it remains below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness suggests a lack of short- and long-term buying momentum.</p>\n<p>Investor participation has increased, with delivery volumes rising by nearly 70% on 04-Dec compared to the five-day average, indicating heightened trading activity. However, this has not translated into price support, as the stock continues to slide.</p>\n<div class=..."
      },
      {
        "title": "How has been the historical performance of Vaishali Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vaishali-pharma-3709127",
        "imagepath": "",
        "date": "2025-11-17 23:20:33",
        "description": "Answer:\nThe historical performance of Vaishali Pharma shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nVaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was as high as 13.09% in March 2023, fell sharply to 0.1% in March 2025. Profit before tax also declined significantly from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025, while profit after tax decreased from INR 6.60 crore to INR 0.82 crore in the same period. The company's total assets increased from INR 66.08 crore in March 2020 to INR 109.66 crore in March 2025, reflecting growth in shareh..."
      },
      {
        "title": "How has been the historical performance of Vaishali Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vaishali-pharma-3703933",
        "imagepath": "",
        "date": "2025-11-15 00:19:10",
        "description": "Answer:\nThe historical performance of Vaishali Pharma shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nVaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was at 13.09% in March 2023, fell drastically to 0.1% in March 2025. Profit before tax also reflected this trend, decreasing from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025. Profit after tax followed a similar pattern, declining from INR 6.60 crore in March 2023 to INR 0.82 crore in March 2025. The company's total liabilities increased from INR 66.08 crore in March 2020 to INR 109.66 crore ..."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3681550",
        "imagepath": "",
        "date": "2025-11-07 23:55:01",
        "description": "As of 07-Nov, Vaishali Pharma Ltd's stock price is currently at 9.74, reflecting a decrease of 0.1, or 1.02%. The stock has underperformed its sector by 0.68% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 2.99%, and it has experienced significant losses year-to-date, down 44.31%. Despite a rise in delivery volume by 49.14% on November 6, indicating increased investor participation, the overall performance remains weak, with no positive factors available to counterbalance the negative trends.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has gained 1.53% over the past month, Vaishali Pharma's performance has been notably poor, with a 13.27% decline during the same period. The stock's year-to-date performance is also concerning, as it has fallen by 44.31% while the Sensex has increased by 7.81%...."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3624253",
        "imagepath": "",
        "date": "2025-10-15 23:20:49",
        "description": "As of 15-Oct, Vaishali Pharma Ltd's stock price is currently at Rs. 10.40, reflecting a decrease of Rs. 0.35, or 3.26%. The stock has hit a new 52-week low of Rs. 10.3 today and has underperformed its sector by 3.34%. Over the past week, the stock has declined by 6.22%, and its year-to-date performance shows a significant drop of 40.54%. The company's long-term fundamentals are weak, evidenced by a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which indicates a risky investment. Additionally, the company's ability to service its debt is poor, with an average EBIT to interest ratio of only 1.68, and its return on equity stands at a low 7.89%.\n\nIn the broader market context, while the Sensex has gained 1.11% over the past week, Vaishali Pharma's performance has sharply contrasted with this upward trend. The stock's delivery volume has also fallen signific..."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3584068",
        "imagepath": "",
        "date": "2025-09-30 23:05:37",
        "description": "As of 30-Sep, Vaishali Pharma Ltd's stock price is currently at 11.31, reflecting a decrease of 0.19, or 1.65%. The stock has underperformed its sector by 1.44% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 5.51%, and it has seen a significant drop of 35.33% year-to-date. The company's delivery volume has also fallen sharply, with a 46.68% decrease compared to the 5-day average, indicating reduced investor participation. Additionally, the company has reported weak long-term fundamentals, including a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which contributes to the stock's recent decline.\n\nIn the broader market context, while the Sensex has experienced a slight decline of 2.22% over the past week, Vaishali Pharma's performance has been significantly worse, hi..."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3568131",
        "imagepath": "",
        "date": "2025-09-24 23:11:21",
        "description": "As of 24-Sep, Vaishali Pharma Ltd's stock price is currently at 11.99, reflecting a slight increase of 0.02 or 0.17%. Despite this minor uptick, the stock has shown a negative performance trend, with a 1-week decline of 0.58% and a year-to-date drop of 31.45%. The stock is trading below its moving averages across various timeframes, indicating a bearish trend. Additionally, there has been a significant decrease in investor participation, with delivery volume falling by 80.88% compared to the 5-day average. The company has also faced challenges, including weak long-term fundamental strength, a negative EBITDA, and a substantial decline in operating profits, which collectively contribute to a perception of risk among investors.\n\nIn the broader market context, Vaishali Pharma's recent performance contrasts with the benchmark Sensex, which has experienced a decline of 1.08% over the past week. While the stock h..."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3562105",
        "imagepath": "",
        "date": "2025-09-23 23:21:41",
        "description": "As of 23-Sep, Vaishali Pharma Ltd's stock price is currently at 11.97, reflecting a decrease of 0.14, or 1.16%. The stock has underperformed its sector by 0.81% today and is trading below all moving averages, indicating a bearish trend. Additionally, the delivery volume has significantly dropped by 88.95% compared to the 5-day average, suggesting a lack of investor interest. Over the past week, the stock has declined by 0.58%, and its year-to-date performance shows a substantial drop of 31.56%. The company's weak long-term fundamentals, highlighted by a -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, further contribute to its declining stock price.\n\nIn the broader market context, the Sensex has experienced a slight decline of 0.28% over the past week, which indicates that the overall market sentiment is somewhat negative but not as severe as Vaishali Pharma's perfor..."
      },
      {
        "title": "Why is Vaishali Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaishali-pharma-fallingrising-3555331",
        "imagepath": "",
        "date": "2025-09-22 23:10:54",
        "description": "As of 22-Sep, Vaishali Pharma Ltd's stock price is currently flat at 12.11, with no change in percentage terms (0.00%). The stock has shown mixed performance in recent periods, with a slight increase of 0.67% over the past week, but a decline of 0.82% over the past month. Today's performance indicates that it has outperformed its sector by 1.08%. However, the stock is trading below its longer-term moving averages, and there has been a significant drop in investor participation, with delivery volume falling by 31.06% against the 5-day average. Additionally, the company has faced challenges, including a weak long-term fundamental strength, a negative EBITDA, and a substantial decline in profitability, as evidenced by a 24.7% fall in PAT for the quarter ending June 25.\n\nIn the broader market context, Vaishali Pharma's recent performance has been relatively better than the benchmark Sensex over the past week, w..."
      }
    ],
    "total": 59,
    "sid": "1002804",
    "stock_news_url": "https://www.marketsmojo.com/news/vaishali-pharma-1002804"
  },
  "announcements": [
    {
      "details": "Vaishali Pharma Limited has informed the Exchange regarding Resignation of Ms Khushboo M Panchal as Company Secretary & Compliance Officer of the company w.e.f. October 31, 2019.",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Resignation",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Vaishali Pharma Limited has informed the Exchange regarding allotment of 3954828 securities pursuant to Bonus at its meeting held on October 19, 2019",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Allotment of Securities",
      "datetime": "22-Oct-2019"
    },
    {
      "details": "Vaishali Pharma Limited has informed the Exchange that the Company has fixed Record Date as October 18, 2019 for the purpose of Allotment of Bonus Shares .(Revised)",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Record Date",
      "datetime": "16-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vaishali Pharma Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Oct 24",
          "dt": "2024-10-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Vaishali Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Oct 24",
          "dt": "2024-10-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vaishali Pharma falling/rising?

2025-12-06 01:40:27

Recent Price Movement and Market Context

Vaishali Pharma’s share price decline on 05-Dec reflects broader challenges the company faces. The stock is trading close to its 52-week low, just 2.02% above ₹8.25, signalling sustained pressure on investor confidence. On the day, the stock underperformed its sector by 2.34%, and it remains below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness suggests a lack of short- and long-term buying momentum.

Investor participation has increased, with delivery volumes rising by nearly 70% on 04-Dec compared to the five-day average, indicating heightened trading activity. However, this has not translated into price support, as the stock continues to slide.

Read More

How has been the historical performance of Vaishali Pharma?

2025-11-17 23:20:33

Answer: The historical performance of Vaishali Pharma shows significant fluctuations in its financial metrics over the years. Breakdown: Vaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was as high as 13.09% in March 2023, fell sharply to 0.1% in March 2025. Profit before tax also declined significantly from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025, while profit after tax decreased from INR 6.60 crore to INR 0.82 crore in the same period. The company's total assets increased from INR 66.08 crore in March 2020 to INR 109.66 crore in March 2025, reflecting growth in shareh...

Read More

How has been the historical performance of Vaishali Pharma?

2025-11-15 00:19:10

Answer: The historical performance of Vaishali Pharma shows significant fluctuations in key financial metrics over the years. Breakdown: Vaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was at 13.09% in March 2023, fell drastically to 0.1% in March 2025. Profit before tax also reflected this trend, decreasing from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025. Profit after tax followed a similar pattern, declining from INR 6.60 crore in March 2023 to INR 0.82 crore in March 2025. The company's total liabilities increased from INR 66.08 crore in March 2020 to INR 109.66 crore ...

Read More

Why is Vaishali Pharma falling/rising?

2025-11-07 23:55:01

As of 07-Nov, Vaishali Pharma Ltd's stock price is currently at 9.74, reflecting a decrease of 0.1, or 1.02%. The stock has underperformed its sector by 0.68% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 2.99%, and it has experienced significant losses year-to-date, down 44.31%. Despite a rise in delivery volume by 49.14% on November 6, indicating increased investor participation, the overall performance remains weak, with no positive factors available to counterbalance the negative trends. Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.53% over the past month, Vaishali Pharma's performance has been notably poor, with a 13.27% decline during the same period. The stock's year-to-date performance is also concerning, as it has fallen by 44.31% while the Sensex has increased by 7.81%....

Read More

Why is Vaishali Pharma falling/rising?

2025-10-15 23:20:49

As of 15-Oct, Vaishali Pharma Ltd's stock price is currently at Rs. 10.40, reflecting a decrease of Rs. 0.35, or 3.26%. The stock has hit a new 52-week low of Rs. 10.3 today and has underperformed its sector by 3.34%. Over the past week, the stock has declined by 6.22%, and its year-to-date performance shows a significant drop of 40.54%. The company's long-term fundamentals are weak, evidenced by a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which indicates a risky investment. Additionally, the company's ability to service its debt is poor, with an average EBIT to interest ratio of only 1.68, and its return on equity stands at a low 7.89%. In the broader market context, while the Sensex has gained 1.11% over the past week, Vaishali Pharma's performance has sharply contrasted with this upward trend. The stock's delivery volume has also fallen signific...

Read More

Why is Vaishali Pharma falling/rising?

2025-09-30 23:05:37

As of 30-Sep, Vaishali Pharma Ltd's stock price is currently at 11.31, reflecting a decrease of 0.19, or 1.65%. The stock has underperformed its sector by 1.44% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 5.51%, and it has seen a significant drop of 35.33% year-to-date. The company's delivery volume has also fallen sharply, with a 46.68% decrease compared to the 5-day average, indicating reduced investor participation. Additionally, the company has reported weak long-term fundamentals, including a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which contributes to the stock's recent decline. In the broader market context, while the Sensex has experienced a slight decline of 2.22% over the past week, Vaishali Pharma's performance has been significantly worse, hi...

Read More

Why is Vaishali Pharma falling/rising?

2025-09-24 23:11:21

As of 24-Sep, Vaishali Pharma Ltd's stock price is currently at 11.99, reflecting a slight increase of 0.02 or 0.17%. Despite this minor uptick, the stock has shown a negative performance trend, with a 1-week decline of 0.58% and a year-to-date drop of 31.45%. The stock is trading below its moving averages across various timeframes, indicating a bearish trend. Additionally, there has been a significant decrease in investor participation, with delivery volume falling by 80.88% compared to the 5-day average. The company has also faced challenges, including weak long-term fundamental strength, a negative EBITDA, and a substantial decline in operating profits, which collectively contribute to a perception of risk among investors. In the broader market context, Vaishali Pharma's recent performance contrasts with the benchmark Sensex, which has experienced a decline of 1.08% over the past week. While the stock h...

Read More

Why is Vaishali Pharma falling/rising?

2025-09-23 23:21:41

As of 23-Sep, Vaishali Pharma Ltd's stock price is currently at 11.97, reflecting a decrease of 0.14, or 1.16%. The stock has underperformed its sector by 0.81% today and is trading below all moving averages, indicating a bearish trend. Additionally, the delivery volume has significantly dropped by 88.95% compared to the 5-day average, suggesting a lack of investor interest. Over the past week, the stock has declined by 0.58%, and its year-to-date performance shows a substantial drop of 31.56%. The company's weak long-term fundamentals, highlighted by a -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, further contribute to its declining stock price. In the broader market context, the Sensex has experienced a slight decline of 0.28% over the past week, which indicates that the overall market sentiment is somewhat negative but not as severe as Vaishali Pharma's perfor...

Read More

Why is Vaishali Pharma falling/rising?

2025-09-22 23:10:54

As of 22-Sep, Vaishali Pharma Ltd's stock price is currently flat at 12.11, with no change in percentage terms (0.00%). The stock has shown mixed performance in recent periods, with a slight increase of 0.67% over the past week, but a decline of 0.82% over the past month. Today's performance indicates that it has outperformed its sector by 1.08%. However, the stock is trading below its longer-term moving averages, and there has been a significant drop in investor participation, with delivery volume falling by 31.06% against the 5-day average. Additionally, the company has faced challenges, including a weak long-term fundamental strength, a negative EBITDA, and a substantial decline in profitability, as evidenced by a 24.7% fall in PAT for the quarter ending June 25. In the broader market context, Vaishali Pharma's recent performance has been relatively better than the benchmark Sensex over the past week, w...

Read More

View All News